Person:
Sneddon, Julie Beth

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Sneddon

First Name

Julie Beth

Name

Sneddon, Julie Beth

Filters

2012 - 20132

Settings

Author's Publications: search.filters.isAuthorOfPublication.a10b5740-0e85-4dd0-b0da-7e79cecd48df

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme
    (Nature Publishing Group, 2012) Sneddon, Julie Beth; Borowiak, Malgorzata; Melton, Douglas
    One goal of regenerative medicine, to use stem cells to replace cells lost by injury or disease, depends on producing an excess of the relevant cell for study or transplantation. To this end, the stepwise differentiation of stem cells into specialized derivatives has been successful for some cell types, but a major problem remains the inefficient conversion of cells from one stage of differentiation to the next. If specialized cells are to be produced in large numbers it will be necessary to expand progenitor cells, without differentiation, at some steps of the process. Using the pancreatic lineage as a model for embryonic-stem-cell differentiation, we demonstrate that this is a solvable problem. Co-culture with organ-matched mesenchyme permits proliferation and self-renewal of progenitors, without differentiation, and enables an expansion of more than a million-fold for human endodermal cells with full retention of their developmental potential. This effect is specific both to the mesenchymal cell and to the progenitor being amplified. Progenitors that have been serially expanded on mesenchyme give rise to glucose-sensing, insulin-secreting cells when transplanted in vivo. Theoretically, the identification of stage-specific renewal signals can be incorporated into any scheme for the efficient production of large numbers of differentiated cells from stem cells and may therefore have wide application in regenerative biology.
  • Thumbnail Image
    Publication
    Brief Report: VGLL4 Is a Novel Regulator of Survival in Human Embryonic Stem Cells
    (AlphaMed Press, 2013) Tajonar, Adriana; Maehr, René; Hu, Guang; Sneddon, Julie Beth; Rivera-Feliciano, Jose; Cohen, Dena Elana; Elledge, Stephen; Melton, Douglas
    Human embryonic stem cells (hESCs) are maintained in a self-renewing state by an interconnected network of mechanisms that sustain pluripotency, promote proliferation and survival, and prevent differentiation. We sought to find novel genes that could contribute to one or more of these processes using a gain-of-function screen of a large collection of human open reading frames. We identified Vestigial-like 4 (VGLL4), a cotranscriptional regulator with no previously described function in hESCs, as a positive regulator of survival in hESCs. Specifically, VGLL4 overexpression in hESCs significantly decreases cell death in response to dissociation stress. Additionally, VGLL4 overexpression enhances hESC colony formation from single cells. These effects may be attributable, in part, to a decreased activity of initiator and effector caspases observed in the context of VGLL4 overexpression. Additionally, we show an interaction between VGLL4 and the Rho/Rock pathway, previously implicated in hESC survival. This study introduces a novel gain-of-function approach for studying hESC maintenance and presents VGLL4 as a previously undescribed regulator of this process.